M. G. Aman, K. S. Lam, and M. E. Van-bourgondien, Medication Patterns in Patients with Autism: Temporal, Regional, and Demographic Influences, Journal of Child and Adolescent Psychopharmacology, vol.15, issue.1, pp.116-126, 2005.
DOI : 10.1089/cap.2005.15.116

A. Amestoy and M. P. Et-bouvard, Troubles du spectre utisti ue : t ts des lieu et d pist e, 2013.

G. M. Anderson, Effects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism, Biological Psychiatry, vol.61, issue.4, pp.545-50, 2007.
DOI : 10.1016/j.biopsych.2006.02.032

. Apa-american-psychiatric-association, Diagnostic and statistical manual of mental disorders Retrieved from http://www.nrdc.org.uk APA American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-5, 1994.

S. Ar-nd-br-n-er, Les tr ite ents ps hotropes pres rits d ns un t blisse ent publi de s nt ent le ueill, 2009.

C. Asso-i-tion-n-tion-le, L'h bit t des personnes e TED : du he soi u i re ense ble : Etude r lis e pour l Dire tion G n r le de l Coh sion So i le, 2011.

A. Fanny, Evolution de personnes adultes avec autisme et déficience intellectuelle : étude rétrospective. Psychologie, 2012.

A. Baghdadli, V. Gonnier, and C. Aussilloux, Review of psychopharmacological treatments in adolescents and adults with autistic disorders, Encephale, vol.28, pp.248-54, 2002.

B. Hd and . Dire, tion so i le Centre r ion l pour l'en n e et l' doles en e in d pt es (2007) Des ription de l' ueil en t blisse ent et ser i es des personnes e des troubles en hiss nts du d eloppe ent : en u te pilote en L n uedo -Roussillon P ris Montpellier: Ministère de l s nt et des solid rit s; CREAI Languedoc Roussillon

A. Baghdadli, Interventions éducatives, pédagogiques et thérapeutiques proposées dans l'autisme : une revue de la littérature, Chapitre, vol.1, 2007.

B. Hd and . Brisot-dubois, Entr îne ent u h bilet s so i les ppli u l' utis e, 2011.

A. Baghdadli, ??tude descriptive de l???utilisation de psychotropes chez les personnes autistes de 20 ?? 35 ans en institution du Languedoc-Roussillon, L'Enc??phale, vol.31, issue.3, pp.302-310, 2005.
DOI : 10.1016/S0013-7006(05)82394-2

J. Barnard, V. Harvey, D. Potter, and A. Prior, Ignored or Ineligible? The Reality for Adults with Autism Spectrum Disorders, 2001.

S. Baron-cohen, Prevalence of autism-spectrum conditions: UK school-based population study, The British Journal of Psychiatry, vol.194, issue.6, pp.500-509, 2009.
DOI : 10.1192/bjp.bp.108.059345

L. Beherec, Retrospective Review of Clozapine in the Treatment of Patients With Autism Spectrum Disorder and Severe Disruptive Behaviors, Journal of Clinical Psychopharmacology, vol.31, issue.3, pp.341-344, 2011.
DOI : 10.1097/JCP.0b013e318218f4a1

A. T. Beck, Cognitive Therapy of Depression, 1979.

D. Bilder, Excess Mortality and Causes of Death in Autism Spectrum Disorders: A Follow up of the 1980s Utah/UCLA Autism Epidemiologic Study, Journal of Autism and Developmental Disorders, vol.289, issue.1, pp.1196-204, 2013.
DOI : 10.1001/jama.289.1.49

E. Billstedt, C. Gillberg, and C. Gillberg, Autism after Adolescence: Population-based 13- to 22-year Follow-up Study of 120 Individuals with Autism Diagnosed in Childhood, Journal of Autism and Developmental Disorders, vol.312, issue.3, pp.351-360, 2005.
DOI : 10.1136/bmj.312.7027.327

L. Bishop-fitzpatrick, Characterizing Objective Quality of Life and Normative Outcomes in Adults with Autism Spectrum Disorder: An Exploratory Latent Class Analysis, Journal of Autism and Developmental Disorders, vol.46, issue.1, pp.2707-2719, 2016.
DOI : 10.1007/s10803-015-2561-z

S. Boelte and F. Poustka, Diagnosis of Autism: The Connection between Current and Historical Information, Autism, vol.151, issue.3, pp.382-390, 2000.
DOI : 10.1176/ajp.151.3.445-a

M. Bouvard, Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study, Psychiatry Research, vol.58, issue.3, pp.191-201, 1995.
DOI : 10.1016/0165-1781(95)02601-R

E. Bradley and P. Bolton, Episodic psychiatric disorders in teenagers with learning disabilities with and without autism, The British Journal of Psychiatry, vol.189, issue.4, pp.361-366, 2006.
DOI : 10.1192/bjp.bp.105.018127

M. Broadstock, C. Doughty, and M. Eggleston, Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder, Autism, vol.106, issue.4, pp.335-348, 2007.
DOI : 10.1352/0895-8017(2001)106<0525:EOROAB>2.0.CO;2

T. Brugha, Epidemiology of Autism Spectrum Disorders in Adults in the Community in England, Archives of General Psychiatry, vol.68, issue.5, pp.459-65, 2011.
DOI : 10.1001/archgenpsychiatry.2011.38

T. Brugha, Outcome measures in intervention trials for adults with autism spectrum disorders; a systematic review of assessments of core autism features and associated emotional and behavioural problems, International Journal of Methods in Psychiatric Research, vol.43, issue.3, pp.99-115, 2015.
DOI : 10.1111/1469-7610.00023

S. Bryson, S. Rogers, and E. Fombonne, Autism Spectrum Disorders: Early Detection, Intervention, Education, and Psychopharmacological Management, The Canadian Journal of Psychiatry, vol.9, issue.8, pp.506-516, 2003.
DOI : 10.1007/s007870070022

J. Buitelar and S. Et-willemsen-swinkels, Medication treatment in subjects with autistic spectrum disorders, European Child & Adolescent Psychiatry, vol.152, issue.S1, pp.85-97, 2000.
DOI : 10.1176/ajp.152.2.248

T. R. Buck, Psychiatric Comorbidity and Medication Use in Adults with Autism Spectrum Disorder, Journal of Autism and Developmental Disorders, vol.289, issue.1, pp.3063-3071, 2014.
DOI : 10.1007/s10803-006-0149-3

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355011/pdf

M. S. Buchsbaum, E. Hollander, and M. M. Haznedar, Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study, The International Journal of Neuropsychopharmacology, vol.4, issue.02, 2001.
DOI : 10.1017/S1461145701002280

C. and N. Tion-le-de, Construire une nou elle t pe de l politi ue des troubles en hiss nts du d eloppe ent et en p rti ulier de l' utis e : http://www.cnsa.fr/documentation/plan_autisme_2008.pdf C isse N tion le de Solid rit pour l'Autono ie (2016) Dossier Te hni ue : Trouble du Spe tre de l'Autis e : Guide d' ppui pour l' l bor tion de r ponses u besoins des personnes pr sent nt des troubles du spe tre de l' utis e http, Autono ie, 2008.

M. Campbell and J. Et-cueva, Psychopharmacology in Child and Adolescent Psychiatry: A Review of the Past Seven Years. Part I, Journal of the American Academy of Child & Adolescent Psychiatry, vol.34, issue.9, pp.1124-1156, 1995.
DOI : 10.1097/00004583-199509000-00008

H. Chabrol, D. Bonnet, and B. Et-roge, Psychopharmacology of autism, Encephale, vol.22, issue.3, pp.197-203, 1996.

J. F. Chossy, Rapport : La situation des personnes autistes en France : besoins et perspectives, 2003.

D. Cohen, Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects, Research in Autism Spectrum Disorders, vol.7, issue.1, pp.167-175, 2013.
DOI : 10.1016/j.rasd.2012.08.001

E. Cook and B. Et-leventhal, The serotonin system in autism, Current Opinion in Pediatrics, vol.8, issue.4, pp.348-354, 1996.
DOI : 10.1097/00008480-199608000-00008

D. L. Coury, Treating the Whole Person With Autism: The Proceedings of the Autism Speaks National Autism Conference, Current Problems in Pediatric and Adolescent Health Care, vol.44, issue.2, pp.26-47, 2014.
DOI : 10.1016/j.cppeds.2013.12.002

C. Languedoc-roussillon, Utilisation des supports visuels pour aider l'enfant autiste au domicile, 2012.

C. Cravero, Traitement médicamenteux reçus par les enfants, adolescents et jeunes adultes avec trouble du spectre autistique en France : un état des lieux basé sur l'expérience parentale. Neuropsychiatrie de l'Enfance et de l'Adolescence, pp.33-41, 2017.
DOI : 10.1016/j.neurenf.2016.10.002

S. Creai-d-'a-uit-ine, Des ription du s stè e de prise en h r e des personnes sou r nt d' utis e d ns l o un ut utono e du P s B s ue et en A uit ine : Pro et euror ionn l sur l'int r tion so i le des eunes utistes, 2015.

C. De-enne-ri-h-rd and D. Et-i-rd, L'H posti ul tion Sensorielle : une r ponse l rise de l' dulte e utis e Le Bulletin scientifique de l'arapi 27, pp.57-63, 2011.

E. Fombonne, R. Zakarian, A. Bennett, L. Meng, and D. Mclean-heywood, Pervasive Developmental Disorders in Montreal, Quebec, Canada: Prevalence and Links With Immunizations, PEDIATRICS, vol.118, issue.1, pp.139-150, 2006.
DOI : 10.1542/peds.2005-2993

E. Fombonne, S. Quirke, and A. Hagen, Epidemiology of pervasive developmental disorders, Autism Spectrum Disorders. Amaral DG, pp.90-111, 2011.
DOI : 10.1203/pdr.0b013e31819e7203

URL : http://www.dds.ca.gov/Autism/docs/AutismReport2003.pdf

T. W. Frazier, Prevalence and Correlates of Psychotropic Medication Use in Adolescents with an Autism Spectrum Disorder with and without Caregiver-Reported Attention-Deficit/Hyperactivity Disorder, Journal of Child and Adolescent Psychopharmacology, vol.21, issue.6, pp.571-579, 2011.
DOI : 10.1089/cap.2011.0057

G. Villamsiar, D. A. Dattilo, and J. , Effects of a leisure programme on quality of life and stress of individuals with ASD, Journal of Intellectual Disability Research, vol.18, issue.7, pp.611-619, 2010.
DOI : 10.1097/00011363-200304000-00008

G. Villamisar, D. Dattilo, and J. , Social and clinical effects of a leisure program on adults with autism spectrum disorder, Research in Autism Spectrum Disorders, vol.5, issue.1, pp.246-253, 2011.
DOI : 10.1016/j.rasd.2010.04.006

N. Garcin and K. Moxness, Traduction Maison, inédite, des critères diagnostic du Trouble du spe tre de l' utis e u DSM-5 : http://autismcanada, 2014.

A. Gilchrist, Development and Current Functioning in Adolescents with Asperger Syndrome: A Comparative Study, Journal of Child Psychology and Psychiatry, vol.42, issue.2, pp.227-240, 2001.
DOI : 10.1111/1469-7610.00714

C. Gillberg, Childhood psychosis and monoamine metabolites in spinal fluid, Journal of Autism and Developmental Disorders, vol.12, issue.4, pp.383-96, 1983.
DOI : 10.1007/BF01531587

K. Gillespie-lynch, L. Sepeta, Y. Wang, S. Marshall, L. Gomez et al., Early Childhood Predictors of the Social Competence of Adults with Autism, Journal of Autism and Developmental Disorders, vol.26, issue.3, pp.161-174, 2012.
DOI : 10.1097/00004583-198703000-00005

G. Gobbi and L. Pulvirenti, Long-term treatment with clozapine in an adult with austistic disorder accompanied by aggressive behaviour, Journal of Psychiatry and Neuroscience, vol.26, pp.340-341, 2001.

O. Golan and S. Baron-cohen, Systemizing empathy: Teaching adults with Asperger syndrome or high-functioning autism to recognize complex emotions using interactive multimedia, Development and Psychopathology, vol.7, issue.02, pp.591-617, 2006.
DOI : 10.1111/1468-5914.00213

T. Grandin, Penser en images . Paris : Editions Odile Jacob, 1997.

K. Gray, C. Keating, J. Taffe, A. Brereton, S. Einfeld et al., Trajectory of Behavior and Emotional Problems in Autism, American Journal on Intellectual and Developmental Disabilities, vol.117, issue.2, pp.121-133, 2012.
DOI : 10.1352/1944-7588-117-2.121

M. Gray, Adult Outcomes in Autism: Community Inclusion and Living Skills, Journal of Autism and Developmental Disorders, vol.3, issue.1, pp.3006-3015, 2014.
DOI : 10.1162/itgg.2008.3.1.11

P. Gringas, Practical Paediatric Psychopharmacological Prescribing in Autism, Autism, vol.12, issue.1, pp.229-276, 2000.
DOI : 10.1515/JPEM.1999.12.1.57

V. Guinchat, Les comorbidités cliniques de l'autisme : une interface entre le syndrome H ute Autorit de S nt et A en e n tion le de l' lu tion et de l u lit des t blisse ents et services sociaux et médi o-so i u (2012) Autis e et utres troubles en hiss nts du d eloppe ent : inter entions du ti es et th r peuti ues oordonn es he l'en nt et l' doles ent re o nd tions M thode Re o nd tion p r onsensus or lis, 2014.

H. Autorité and D. Santé, Autis e et utres troubles en hiss nts du d eloppe ent : les inter entions et le pro et personn lis he l' dulte. Note de cadrage, Service des bonnes pratiques professionnelles (HAS) et service des recommandations (Anesm), 2015.

F. Happé, Demographic and Cognitive Profile of Individuals Seeking a Diagnosis of Autism Spectrum Disorder in Adulthood, Journal of Autism and Developmental Disorders, vol.35, issue.11, pp.10803-10819, 1007.
DOI : 10.1007/s10803-005-3300-7

D. J. Hare, C. Pratt, and M. Burton, The health and social care needs of family carers supporting adults with autistic spectrum disorders, Autism, vol.19, issue.3, pp.425-444, 2004.
DOI : 10.1007/BF02212727

D. Hedley, Transition to work: Perspectives from the autism spectrum, Autism, vol.57, pp.1362361316687697-10, 2017.
DOI : 10.1007/s10803-005-3300-7

Y. Hsia, Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study, Psychopharmacology, vol.2, issue.1, pp.999-1009, 2014.
DOI : 10.1186/1753-2000-2-26

A. Hillier, T. Fish, and P. Cloppert, Outcomes of a Social and Vocational Skills Support Group for Adolescents and Young Adults on the Autism Spectrum, Focus on Autism and Other Developmental Disabilities, vol.11, issue.2, pp.107-115, 2007.
DOI : 10.1177/1359104506059119

B. Hofvander, Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders, BMC Psychiatry, vol.6, issue.Suppl 3, p.35, 2009.
DOI : 10.1177/1362361302006003006

URL : https://hal.archives-ouvertes.fr/inserm-00410731

E. Hollander, A. Phillips, and C. Yeh, Targeted treatments for symptom domains in child and adolescent autism, The Lancet, vol.362, issue.9385, pp.732-734, 2003.
DOI : 10.1016/S0140-6736(03)14236-5

E. Hollander, A. Phillips, and W. Chaplin, A Placebo Controlled Crossover Trial of Liquid Fluoxetine on Repetitive Behaviors in Childhood and Adolescent Autism, Neuropsychopharmacology, vol.30, issue.3, 2005.
DOI : 10.1038/sj.npp.1300627

K. Horvath, Improved social and language skills after secretin administration in patients with autistic spectrum disorders, J Assoc Acad Minor Phys, vol.9, pp.9-15, 1998.

P. Howlin, Autism and Asperger Syndrome: Preparing for Adulthood Out o e in dult li e or people with utis nd Asper er's syndrome, Autism and pervasive developmental disorders, pp.209-241, 1997.
DOI : 10.4324/9780203426913

P. Howlin and P. Yates, The Potential Effectiveness of Social Skills Groups for Adults with Autism, Autism, vol.19, issue.2, pp.299-307, 1999.
DOI : 10.1007/BF02212726

P. Howlin, Outcome in Adult Life for more Able Individuals with Autism or Asperger Syndrome, Autism, vol.36, issue.3, pp.63-83, 2000.
DOI : 10.1111/j.1469-7610.1995.tb01330.x

P. Howlin, P. Moss, S. Savage, and M. Rutter, Social Outcomes in Mid- to Later Adulthood Among Individuals Diagnosed With Autism and Average Nonverbal IQ as Children, Journal of the American Academy of Child & Adolescent Psychiatry, vol.52, issue.6, pp.52-572, 2013.
DOI : 10.1016/j.jaac.2013.02.017

P. Howlin and S. Savage, Cognitive and language skills in adults with autism: a 40-year follow-up, Journal of Child Psychology and Psychiatry, vol.45, issue.1, 2013.
DOI : 10.1111/j.1469-8749.2003.tb00950.x

K. Hurlbutt and L. Chalmers, Employment and Adults With Asperger Syndrome, Focus on Autism and Other Developmental Disabilities, vol.17, issue.4, pp.215-222, 2004.
DOI : 10.1017/CBO9780511526770.003

L. Jahromi, C. Kasari, and J. Mccracken, Positive Effects of Methylphenidate on Social Communication and Self-Regulation in Children with Pervasive Developmental Disorders and Hyperactivity, Journal of Autism and Developmental Disorders, vol.74, issue.3, pp.395-404, 2009.
DOI : 10.1093/acprof:oso/9780195168716.003.0004

M. Jennes-coussens, J. Magill-evans, and C. Koning, The quality of life of young men with Asperger syndrome, Autism, vol.28, issue.1, pp.403-414, 2006.
DOI : 10.1017/S0033291798006667

N. Y. Ji and R. L. Findling, An update on pharmacotherapy for autism spectrum disorder in children and adolescents, Current Opinion in Psychiatry, vol.28, pp.91-101, 2015.

K. Jobski, Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review, Acta Psychiatrica Scandinavica, vol.35, issue.Suppl 2, pp.8-28, 2017.
DOI : 10.1016/j.ridd.2014.08.025

L. Kanner, Autistic disturbances of affective contact, Nerv Child, vol.2, pp.217-247, 1943.

R. Khanna, Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme, Journal of Intellectual Disability Research, vol.61, issue.2, pp.161-71, 2013.
DOI : 10.1097/00006842-199909000-00008

B. H. King, Pharmacological treatment of mood disturbances, agression and self-injury in persons with pervasive developmental disorders, Journal of Autism and Developmental Disorders, vol.30, issue.5, pp.439-484, 2000.
DOI : 10.1023/A:1005555624566

B. H. King, E. Hollander, and L. Sikich, Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior, Archives of General Psychiatry, vol.66, issue.6, pp.583-90, 2009.
DOI : 10.1001/archgenpsychiatry.2009.30

M. M. Konstantareas and S. Homatidis, Assessing Child Symptom Severity and Stress in Parents of Autistic Children, Journal of Child Psychology and Psychiatry, vol.10, issue.3, pp.459-470, 1989.
DOI : 10.1007/BF01531605

S. Krishnaswami, M. L. Mcpheeters, and J. Veenstra-vanderweele, A Systematic Review of Secretin for Children With Autism Spectrum Disorders, PEDIATRICS, vol.127, issue.5, pp.1322-1325, 2011.
DOI : 10.1542/peds.2011-0428

G. M. Kuijper and P. J. Hoekstra, Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability, Journal of Intellectual Disability Research, vol.27, issue.10, 2017.
DOI : 10.1089/cap.2015.0123

M. Lai, Autism, The Lancet, vol.383, issue.9920, pp.896-910, 2014.
DOI : 10.1016/S0140-6736(13)61539-1

URL : https://hal.archives-ouvertes.fr/pasteur-01557950

G. S. Liptak, J. A. Kennedy, and N. P. Dosa, Social Participation in a Nationally Representative Sample of Older Youth and Young Adults With Autism, Journal of Developmental & Behavioral Pediatrics, vol.32, issue.4, pp.277-283, 2011.
DOI : 10.1097/DBP.0b013e31820b49fc

I. Lott, Longitudinal prescribing patterns for psychoactive medications in community-based individuals with developmental disabilities: utilization of pharmacy records, Journal of Intellectual Disability Research, vol.34, issue.6, pp.563-571, 2004.
DOI : 10.1352/0895-8017(2001)106<0525:EOROAB>2.0.CO;2

J. Lounds, M. M. Seltzer, and J. S. Greenberg, Transition and Change in Adolescents and Young Adults With Autism: Longitudinal Effects on Maternal Well-Being, American Journal on Mental Retardation, vol.112, issue.6, pp.401-417, 2007.
DOI : 10.1352/0895-8017(2007)112[401:TACIAA]2.0.CO;2

J. Luby, Risperidone in Preschool Children with Autistic Spectrum Disorders: An Investigation of Safety and Efficacy, Journal of Child and Adolescent Psychopharmacology, vol.16, issue.5, pp.575-87, 2006.
DOI : 10.1089/cap.2006.16.575

I. Magiati, X. W. Tay, and P. Howlin, Cognitive, language, social and behavioural outcomes in adults with autism spectrum disorders: A systematic review of longitudinal follow-up studies in adulthood, Clinical Psychology Review, vol.34, issue.1, pp.73-86, 2014.
DOI : 10.1016/j.cpr.2013.11.002

D. S. Mandell, K. H. Morales, S. C. Marcus, A. C. Stahmer, J. Doshi et al., Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum Disorders, PEDIATRICS, vol.121, issue.3, pp.441-448, 2008.
DOI : 10.1542/peds.2007-0984

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861431/pdf

J. Manzano, M. Lamuière, and M. Peckova, L'enfant psychotique devenu adulte, Neuropsy Enf Ado, vol.35, pp.429-472, 1987.

D. Marcelli, Enfance et psychopathologie. 5ème édition, 1996.
URL : https://hal.archives-ouvertes.fr/halshs-00635434

R. N. Marcus, A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder, Journal of the American Academy of Child & Adolescent Psychiatry, vol.48, issue.11, pp.1110-1119, 2009.
DOI : 10.1097/CHI.0b013e3181b76658

S. U. Marks, C. Schrader, and T. Longaker, Portraits of three adolescent students with Asper er's s ndro e: person l stories nd how the n in or pr ti e The Journal of the Association for Persons with Severe Handicaps, pp.3-17, 2000.

J. Matson and T. Dempsey, Autism Spectrum Disorders: Pharmacotherapy for Challenging Behaviors, Journal of Developmental and Physical Disabilities, vol.153, issue.Supplement 2, pp.175-191, 2008.
DOI : 10.1097/00006842-199909000-00008

L. Mawhood, P. Howlin, and M. Rutter, Autism and Developmental Receptive Language Disorder???a Comparative Follow-up in Early Adult Life. I: Cognitive and Language Outcomes, Journal of Child Psychology and Psychiatry, vol.34, issue.5, pp.547-559, 2000.
DOI : 10.1044/jshr.3405.1150

J. T. Mccracken, Risperidone in Children with Autism and Serious Behavioral Problems, New England Journal of Medicine, vol.347, issue.5, pp.314-335, 2002.
DOI : 10.1056/NEJMoa013171

C. J. Mcdougle, A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic Disorder, Archives of General Psychiatry, vol.53, issue.11, pp.1001-1009, 1996.
DOI : 10.1001/archpsyc.1996.01830110037005

C. J. Mcdougle, A Double-blind, Placebo-Controlled Study of Risperidone in Adults With Autistic Disorder and Other Pervasive Developmental Disorders, Archives of General Psychiatry, vol.55, issue.7, pp.633-674, 1998.
DOI : 10.1001/archpsyc.55.7.633

C. Mcdougle, L. Scahill, and J. Mccracken, Research Units on Pediatric Psychopharmacology (RUPP) Autism Network: background and rationale for an initial controlled study of risperidone, Child Adolesc Psychiatr Clin N Am, vol.9, pp.201-224, 2000.

C. W. Mcgovern and M. Sigman, Continuity and change from early childhood to adolescence in autism, Journal of Child Psychology and Psychiatry, vol.63, issue.4, pp.401-408, 2005.
DOI : 10.1023/A:1014884404276

J. M. Mcqueen and A. M. Heck, Secretin for the Treatment of Autism, Annals of Pharmacotherapy, vol.107, issue.2, pp.305-316, 2002.
DOI : 10.1542/peds.107.1.1

S. Ministère-de-l, . Nt, and . Des, Solid rit s -Direction Générale de l'Action Sociale ? Baghdadli A. (2007) Interventions éducatives, pédagogiques et thérapeutiques proposées dans l'autisme : https

A. Ministère-des, S. Ires-so-i-les-et-de-l, and . Nt, 16 : i he tion « A ès u soins so ti ues, 2013.

A. Ministère-des, S. Ires-so-i-les-et-de-l, and . Nt, R pport pr sent l Se r t ire d'Et t h r e des Personnes h ndi p es et de l Lutte ontre l'exclusion, 2017.

A. Ministère-des, S. Ires-so-i-les-et-de-l, and . Nt, Commission scientifique intern tion le sur l' utis e : S nthèse des tes, 2017.

S. Miral, O. Gencer, F. N. Inal-emiroglu, B. Baykara, A. Baykara et al., Risperidone versus haloperidol in children and adolescents with AD, European Child & Adolescent Psychiatry, vol.10, issue.2, 2008.
DOI : 10.1007/s007870070014

D. Monto and S. Bod-rt, Le programme Makaton aupr??s d'un enfant porteur d'autisme??: le cas de Julien, D??veloppements, vol.3, issue.3, pp.15-26, 2009.
DOI : 10.3917/devel.003.0015

C. N. Morgan, M. Roy, and P. Chance, Psychiatric comorbidity and medication use in autism: a community survey, Psychiatric Bulletin, vol.27, issue.10, pp.378-381, 2003.
DOI : 10.1192/pb.27.10.378

M. Murray, Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care, Psychopharmacology, vol.51, issue.10, pp.1011-1021, 2014.
DOI : 10.1177/0009922812440837

S. M. Myers, The status of pharmacotherapy for autism spectrum disorders, Expert Opinion on Pharmacotherapy, vol.19, issue.11, pp.1579-1603, 2007.
DOI : 10.1176/appi.psy.47.1.75

R. Nagaraj, P. Singhi, and P. Malhi, Risperidone in Children With Autism: Randomized, Placebo-Controlled, Double-Blind Study, Journal of Child Neurology, vol.13, issue.6, pp.450-455, 2006.
DOI : 10.1097/00004583-198907000-00012

G. I. Orsmond, M. W. Krauss, and M. M. Seltzer, Peer Relationships and Social and Recreational Activities Among Adolescents and Adults with Autism, Journal of Autism and Developmental Disorders, vol.34, issue.3, pp.245-256, 2004.
DOI : 10.1023/B:JADD.0000029547.96610.df

R. Owen, Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder, PEDIATRICS, vol.124, issue.6, pp.1533-1540, 2009.
DOI : 10.1542/peds.2008-3782

T. Paul and . Shattuck, Change in Autism Symptoms and Maladaptive Behaviors in Adolescents and Adults with an Autism Spectrum Disorder, J Autism Dev Disord, vol.37, pp.1735-1747, 2007.

P. , D. Guin-h-t-hellin-s, A. Hd-dli, and A. , Tr ite ent ph r olo i ue des o porte ents probl ti ues sso i s u troubles du spe tre utisti ue : re ue de l litt r ture. Neuropsyc iatrie de l'enfance et de l, pp.42-51, 2012.

J. Piven, J. Harper, P. Palmer, and S. Arndt, Course of Behavioral Change in Autism: A Retrospective Study of High-IQ Adolescents and Adults, Journal of the American Academy of Child & Adolescent Psychiatry, vol.35, issue.4, pp.523-529, 1996.
DOI : 10.1097/00004583-199604000-00019

D. J. Posey and C. J. Et-mc-dougle, The Pharmacotherapy of Target Symptoms Associated with Autistic Disorder and Other Pervasive Developmental Disorders, Harvard Review of Psychiatry, vol.8, issue.2, pp.45-63, 2000.
DOI : 10.1080/hrp_8.2.45

D. J. Posey, C. A. Erickson, and K. A. Stigler, The Use of Selective Serotonin Reuptake Inhibitors in Autism and Related Disorders, Journal of Child and Adolescent Psychopharmacology, vol.16, issue.1-2, pp.181-187, 2006.
DOI : 10.1089/cap.2006.16.181

D. J. Posey, K. Stigler, C. Erickson, and C. Mcdougle, Antipsychotics in the treatment of autism, Journal of Clinical Investigation, vol.118, issue.1, pp.6-14, 2008.
DOI : 10.1172/JCI32483

M. Prior and S. Ozonoff, Psychological factors in autism Autism and Pervasive Developmental Disorders, pp.64-98, 1998.

B. Rogé, Autisme : de l'enfance à l'âge adulte. Sous la direction de Catherine Barthélémy et Frédérique Bonnet-Brilhault, 2012.

D. J. Safer, Changing Patterns of Psychotropic Medications Prescribed by Child Psychiatrists in the 1990s, Journal of Child and Adolescent Psychopharmacology, vol.7, issue.4, pp.267-74, 1997.
DOI : 10.1089/cap.1997.7.267

D. Saravane, B. Feve, Y. Frances, E. Corruble, C. Lancon et al., Elaboration de recommandations pour le sui i so ti ue des p tients tteints de p tholo ie ent le s ère. ncép ale, pp.330-339, 2009.

A. Scheifes, Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psyhotropic drugs, Research in Developmental Disabilities, pp.49-50, 2016.

. Shavelle, Causes of death in autism, Journal of Autism and Developmental Disorders, vol.31, issue.6, pp.569-76, 2001.
DOI : 10.1023/A:1013247011483

S. Shea, Risperidone in the Treatment of Disruptive Behavioral Symptoms in Children With Autistic and Other Pervasive Developmental Disorders, PEDIATRICS, vol.114, issue.5, pp.634-675, 2004.
DOI : 10.1542/peds.2003-0264-F

R. Sheehan, Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study, BMJ, vol.351, 2015.
DOI : 10.1136/bmj.h4326

URL : http://www.bmj.com/content/bmj/351/bmj.h4326.full.pdf

E. Simonoff, Psychiatric Disorders in Children With Autism Spectrum Disorders: Prevalence, Comorbidity, and Associated Factors in a Population-Derived Sample, Journal of the American Academy of Child & Adolescent Psychiatry, vol.47, issue.8, pp.921-929, 2008.
DOI : 10.1097/CHI.0b013e318179964f

L. E. Smith, M. J. Maenner, and M. M. Seltzer, Developmental Trajectories in Adolescents and Adults With Autism: The Case of Daily Living Skills, Journal of the American Academy of Child & Adolescent Psychiatry, vol.51, issue.6, pp.622-631, 2012.
DOI : 10.1016/j.jaac.2012.03.001

P. Sturmey, Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials, Research in Developmental Disabilities, vol.26, issue.1, pp.87-97, 2005.
DOI : 10.1016/j.ridd.2004.09.002

Y. Sugie, H. Sugie, and T. Fukuda, Clinical Efficacy of Fluvoxamine and Functional Polymorphism in a Serotonin Transporter Gene on Childhood Autism, Journal of Autism and Developmental Disorders, vol.30, issue.3, pp.377-85, 2005.
DOI : 10.1097/00004583-199011000-00032

P. Szatmari, S. Bryson, E. Duku, L. Vaccarella, L. Zwaigenbaum et al., Similar developmental trajectories in autism and Asperger syndrome: from early childhood to adolescence, Journal of Child Psychology and Psychiatry, vol.35, issue.12, pp.1459-1467, 2009.
DOI : 10.1093/acprof:oso/9780195152968.001.0001

L. J. Taylor, Psychopharmacologic intervention for adults with autism spectrum disorder: A systematic literature review, Research in Autism Spectrum Disorders, vol.25, pp.58-75, 2016.
DOI : 10.1016/j.rasd.2016.01.011

L. Tsai, Psychopharmacology in Autism, Psychosomatic Medicine, vol.61, issue.5, pp.651-655, 1999.
DOI : 10.1097/00006842-199909000-00008

E. Tsakanikos, H. Costello, G. Holt, P. Sturmey, and N. Bouras, Behaviour Management Problems as Predictors of Psychotropic Medication and Use of Psychiatric Services in Adults with Autism, Journal of Autism and Developmental Disorders, vol.37, issue.6, pp.1080-1085, 2007.
DOI : 10.4324/9780203426913

J. Tsiouris, Pharmacotherapy for aggressive behaviours in persons with intellectual disabilities: treatment or mistreatment?, Journal of Intellectual Disability Research, vol.5, issue.1, pp.1-16, 2010.
DOI : 10.4088/JCP.v64n0914

V. Schalkwyk and G. I. , Autism Spectrum Disorders, Child and Adolescent Psychiatric Clinics of North America, vol.26, issue.2, pp.329-339, 2017.
DOI : 10.1016/j.chc.2016.12.013

J. Volavka, Neurobiology of violence, 1995.

F. Volkmar, C. Lord, A. Bailey, R. Schultz, and A. Klin, Autism and pervasive developmental disorders, Journal of Child Psychology and Psychiatry, vol.37, issue.12, pp.135-155, 2004.
DOI : 10.1037//0033-2909.124.3.283

M. Wagner, L. Newman, and R. Cameto, After High School: a First Look at the Postschool Experiences of Youth with Disabilities. A Report from the National Longitudinal Transition Study-2 (NLTS-2), 2005.

P. Wehman, P. J. Mclaughlin, and T. Wehman, Intellectual and Developmental Disabilities: Toward Full Community Inclusion, pp.PRO-ED, 2005.

A. J. Whitehouse and H. J. Watt, Adult psychosocial outcomes of children with specific language impairment, pragmatic language impairment and autism, International Journal of Language & Communication Disorders, vol.44, issue.4, pp.511-528, 2009.
DOI : 10.1080/13682820802708098

L. C. Wolf, S. Noh, and S. N. Fisman, Brief report: Psychological effects of parenting stress on parents of autistic children, Journal of Autism and Developmental Disorders, vol.31, issue.1, pp.157-166, 1989.
DOI : 10.1001/archpsyc.1984.01790210041006

A. Y. Wong, Y. Hsia, E. W. Chan, D. G. Murphy, E. Simonoff et al., The Variation of Psychopharmacological Prescription Rates for People With Autism Spectrum Disorder (ASD) in 30 Countries, Autism Research, vol.2, issue.Suppl. 2, pp.543-54, 2014.
DOI : 10.1186/1753-2000-2-26

S. Woolfenden, A systematic review of two outcomes in autism spectrum disorder - epilepsy and mortality, Developmental Medicine & Child Neurology, vol.137, issue.Pt 2, p.672, 2012.
DOI : 10.1093/brain/awq378

K. E. Zuckerman, Overweight and Obesity: Prevalence and Correlates in a Large Clinical Sample of Children with Autism Spectrum Disorder, Journal of Autism and Developmental Disorders, vol.42, issue.4, pp.1708-1727, 2014.
DOI : 10.1007/s10803-011-1268-z

A. Zuddas, Clinical effects of clozapine on autistic disorder, Am J Psychiatry, vol.153, p.738, 1996.